Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy
IntroductionGlioblastoma (GBM) presents significant challenges due to its malignancy and limited treatment options. Precision treatment requires subtyping patients based on prognosis. Disulfidptosis, a novel cell death mechanism, is linked to aberrant glucose metabolism and disulfide stress, particu...
Main Authors: | Xue Yang, Zehao Cai, Ce Wang, Chenggang Jiang, Jianguang Li, Feng Chen, Wenbin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1362543/full |
Similar Items
-
Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma
by: Qian Jiang, et al.
Published: (2024-03-01) -
Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma
by: Jiajing Zhao, et al.
Published: (2023-12-01) -
Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis
by: Kai Xu, et al.
Published: (2023-06-01) -
Prognostic and immune infiltration features of disulfidptosis-related subtypes in breast cancer
by: Sheng Chen, et al.
Published: (2024-01-01) -
Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma
by: Juan Xu, et al.
Published: (2024-03-01)